Antibodies against Latent Myostatin could treat muscle wasting in elderly

could reach either 18,735,173 (a 72% rise), or with higher estimates 32,338,990 (a 63.8% rise) by 2045. Lowered levels of myostatin result in less fat and more muscle in humans and other mammals. Complete removal of myostatin via genetic engineering or rare natural mutation has resulted in very heavily muscled mice, dogs, cows, and even …

Read more

Reinventing the wheel, robots, drones and transportation with the Revolve Foldable wheel

Revolve has a groundbreaking innovation – the foldable wheel. The foldable wheel including a double hub, a rim with rubberized sectors, and spokes pivotly connecting each hub with the sectors of the rim. The sectors of the rim can be figured, starting from an extended condition of forming the wheel in which the hubs are …

Read more

AgeX to develop powerful regenerative and anti-aging treatments

AgeX Therapeutics, Inc. is a biotechnology company formed in 2017 as a subsidiary of BioTime, Inc (NYSE MKT: BTX). Its mission is to apply technology related to cell immortality and pluripotency to human aging and age-related disease. The Company’s technology platform has three facets: Pluripotent stem cell-derived progenitor cell lines representing over 200 types of …

Read more

Foresight Visions – Reaching Longevity Escape Velocity

The Foresight vision weekend has its first panel Sonia Arrison, Aubrey De Grey, Max More, Kevin Perrott compare strategies to extend human healthspans – Snake oil vs the holy grail – cryonics – overpopulation vs stabilization – There is Existential Hope website is tracking all of the topics at the Vision Weekend. Increased Healthplan does …

Read more

Foresight Institute Vision Weekend starts tomorrow

The Foresight Institute Vision Weekend is a gathering dedicated to taking stock of the most compelling ideas of today, turn them into coherent visions for a better future, and get to work on them. Saturday: Keynote panels at Gray Area. Industry-leaders deliver food for thought during panels, followed by private Q&A tables with your favorite …

Read more

Step to fully decoding the biology of blood vessel growth which will help fix major medical problems

Researchers have identified a signaling pathway that is essential for the growth of new blood vessels from pre-existing vessels. This can be used to improve blood flow in ischemic tissue which will help with fixing atherosclerosis (clogged arteries) and peripheral vascular disease associated with diabetes. Nature Communications – R-Ras-Akt axis induces endothelial lumenogenesis and regulates …

Read more

21st century peace from aging populations, debt, pension and medical costs

The US and China are both having worsening pension and medical costs which will vastly restrict the money available for military programs and wars. By 2040, China could have $10 to 100 trillion in unfunded pension costs. China is about to experience the most rapid aging crisis in human history, with the ratio of workers-to-retirees …

Read more

Drug trodusquemine has weight loss benefits and trials for treating breast cancer, diabetes and heart disease

A new mouse study has shown that the drug trodusquemine can melt away the accumulated arterial plaques that lead to heart attacks and strokes. Atherosclerosis is the number one killer in the world. Cardiovascular disease (CVD) is a general term used to describe all the conditions affecting the heart and blood vessels and is responsible …

Read more

Extending Healthy Human Lifespan is Near

In 2014, Life Extension Advocacy Foundation was established to promote increased healthy human lifespan through fiscally sponsoring longevity research projects and raising awareness regarding the societal benefits of life extension. In 2015 they launched Lifespan.io, the first nonprofit crowdfunding platform focused on the biomedical research of aging. Here is a video based on Lifespan.io biomedical …

Read more

Blood plasma infusions from young donors improves functional ability for Alzheimers

Stanford University School of Medicine investigators have reported success in an early-phase clinical trial examining the safety, tolerability and feasibility of administering infusions of blood plasma from young donors to participants with mild to moderate Alzheimer’s disease. There were also some signs suggesting improvements in participants’ conditions. Above – Sharon Sha presented findings Nov. 4 …

Read more